Some Global Policies for Antibiotic Resistance Depend on Legally Binding and Enforceable Commitments

Ardal C. Outterson K. Hoffman S. J. Ghafur A. Sharland M. Ranganthan N. , “International Collaboration to Improve Access to and Sustain Effectiveness of Antimicrobials,” The Lancet (in press).

Laxminarayan R. Duse A. Wattal C. Zaidi A. K. M. Wertheim H. F. L. Sumpradit N. , “Antibiotic Resistance - The Need for Global Solutions,” The Lancet Infectious Diseases 13, no. 12 (2013): 1057–1098.

World Health Organization: Draft Global Action Plan on Antimicrobial Resistance, World Health Organization, available at <http://www.who.int/drugresistance/AMR_DRAFT_GAP_1_Oct_2014_for_MS_consultation.pdf> (last visited May 29, 2015).

Hoffman S. J. Outterson K. Røttingen J.-A. Cars O. Clift C. Rizvi Z. , “An International Legal Framework to Address Antimicrobial Resistance,” Bulletin of the World Health Organization 93, no. 2 (2015): 66.

Hoffman S. J. Røttingen J.-A. Frenk J. , “International Law Has a Role to Play in Addressing Antibiotic Resistance,” Journal of Law, Medicine & Ethics 43, no. 2, Supp. (2015): Available via aslme.org.

Hoffman S. J. Røttingen J.-A. Frenk J. , “Assessing Proposals for New Global Health Treaties: An Analytic Framework,” American Journal of Public Health (2015): e1–e8.

See WHO, supra note 3.

Hoffman S. J. McGrady B. Caleo G. M. Daulair N. Elbe S. Wong D. L. F. , “Achieving Global Collective Action For Improving Access to Antimicrobials and Sustaining Their Effectiveness,” in preparation; Edge J. S. Hoffman S. J. , “Empirical Impact Evaluation of the WHO Global Code of Practice on the International Recruitment of Health Personnel in Australia, Canada, UK and USA,” Globalization & Health 9, no. 60 (2013): 1–10.

Spellberg B. Bartlett J. G. Gilbert D. N. , “The Future of Antibiotics and Resistance,” New England Journal of Medicine 368, no. 4 (2013): 299–302.

Huttner A. Harbarth S. Carlet J. Cosgrove S. Goossens H. Holmes A. , “Antimicrobial Resistance: A Global View From the 2013 World Healthcare-Associated Infections Forum,” Antimicrobial Resistance and Infection Control 2, no. 31 (2013): 1–13; Van Boeckel T. P. Brower C. Gilbert M. Grenfell B. T. Levin S. A. Robinson T. P. , “Global Trends in Antimicrobial Use in Foods,” Proceedings of the National Academy of Sciences of the United States of America 112, no. 18 (2013): 5649–5654.

World Health Organization, The Evolving Threat of Antimicrobial Resistance , (2012), available at <http://www.who.int/patientsafety/implementation/amr/publication/en/> (last visited June 1, 2015).

Hoffman S. J. Røttingen J.-A. , “Be Sparing With International Laws,” Nature 483, no. 7389 (2012): 275; Hoffman S. J. Røttingen J.-A. , “Assessing Implementation Mechanisms For an International Agreement On Research and Development For Health Products,” Bulletin of the World Health Organization 90 (2012): 854–863; Hoffman S. J. Ottersen T. , “Addressing Antibiotic Resistance Requires Robust International Accountability Mechanisms,” Journal of Law, Medicine & Ethics 43, no. 2, Supp. (2015): Available via aslme.org.

Le Doare K. Barker C. I. S. Irwin A. Sharland M. , “Improving Antibiotic Prescribing for Children in the Resource-Poor Setting,” British Journal of Clinical Pharmacology 79, no. 3, (2015): 446–455.

Leung E. Weil D. E. Raviglione M. Nakatani H. , “Policy Package to Combat Antimicrobial Resistance,” World Health Organization World Health Day Antimicrobial Resistance Technical Working Group, available at <http://www.reactgroup.org/uploads/publications/other-publications/WHO-Policy-Package-to-Combat-Antimicrobial-Resistance.pdf> (last visited June 1, 2015).

See Hoffman Røttingen (“Assessing Implementation”), supra note 12.

See Leung , supra note 15.

Vernet G. Mary C. Altmann D. M. Doumbo O. Morpeth S. Bhutta Z. A. , “Surveillance for Antimicrobial Drug Resistance in Under-Resourced Countries,” Emerging Infectious Diseases 20, no. 3 (2014): 434–441.

Henriksen L. , “Comprehensive Tobacco Marketing Restrictions: Promotion, Packaging, Price, and Place,” Tobacco Control 21, no. 2 (2012): 147–153.

Røttingen J.-A. Chamas C. , “A New Deal for Global Health R&D? The Recommendations of the Consultative Expert Working Group on Research and Development,” PLOS Medicine 9, no. 5 (2012): e1001219.

WHO Consultative Expert Working Group on Research and Development, “Research and Development to Meet Health Needs in Developing Countries: Strengthening Global Financing and Coordination,” WHO, available at <http://www.who.int/phi/cewg_report/en/> (last visited June 1, 2015); Rizvi Z. Hoffman S. J. , “Effective Global Action on Antibiotic Resistance Requires Careful Consideration of Convening Forums,” Journal of Law, Medicine & Ethics 43, no. 2, Supp. (2015): Available via aslme.org.

Hoffman S. J. Røttingen J.-A. , “Assessing the Expected Impact of Global Health Treaties: Evidence from 90 Quantitative Evaluations,” American Journal of Public Health 105, no. 1 (2015): 26–40.